Mamotest key facts
- Operator of a telemammography network intended to democratize access to breast cancer screening and early detection.The company offers a network of standardized, certified telemammography centers…
- It has raised $6.1M; the latest was Accelerator/Incubator ($70K) in Sep 2024.
- Notable investors include Hub71, MIT Solve, Acelerar España, Johnson & Johnson Services, Sonen Capital — 13 tracked in total.
- Status: Privately Held (backing).
Who backs Mamotest
13+- ·The complete investor list: 13 names
- ·Watch Mamotest: the Monday email on marks, rounds and moves
Mamotest funding rounds
No funding rounds for Mamotest are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Mamotest investors
13 investors are on record for Mamotest, including Hub71, MIT Solve, Acelerar España and Johnson & Johnson Services.
About Mamotest
Operator of a telemammography network intended to democratize access to breast cancer screening and early detection.The company offers a network of standardized, certified telemammography centers equipped with digital mammography technology and remote expert interpretation, enabling customers, particularly in underserved regions, to access high-quality, affordable breast cancer screening and receive timely diagnoses, ultimately improving survival rates and reducing disparities in healthcare access.
- Sector
- Healthcare
- HQ
- Mexico City, Mexico
- Founded
- 2013
- Employees
- 29
- Website
- mamotest.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Mamotest doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.